OTC Acne Treatment Labels Should Add Sensitivity Test Direction – FDA
This article was originally published in The Rose Sheet
Executive Summary
Manufacturers of OTC topical acne drug products should consider including text on labeling that instructs new uses in sensitivity testing “to reduce the risk of serious hypersensitivity reactions,” FDA says.